©2014 Topcon Corporation 33

SIC： Enhance new business with strong basis of surveying instruments ECC： Strengthen Prognostic Management and Treatment Segment by enforcing competitiveness of Examination/Diagnosis Segment

Ⅰ. Mid-Term Business Plan 2016 Ⅰ-1. Vision for Mid-Term Business Plan Ⅰ-2. Strategic Plans on Mid-Term Business Plan Ⅰ-3. Financial Targets

POC： Accelerating IT Construction and IT Agriculture with strong GNSS core technology

Ⅰ-4. Strategic Plans by Companies

©2014 Topcon Corporation

Expand Business Field

Preventive Medicine / Physical check-up

Treatment/ Prognostic

Management Examination Diagnostic

Expansion of Business Field

Current Business Field

Ophthalmic IT

34

Strengthen Preventive Medicine and Treatment Segment by Enhancing the Strong Competitive of Examination/Diagnosis Segment

Sharing data with Cloud System and providing regional Medical cooperation service

Business Domain

©2014 Topcon Corporation

0

100

200

300

400

2012 2013 2020

World population Under 15 y (Ratio of population) Over 65 y (Ratio of population)

(Unit: Million people)

Business Environment <Global trend>

Progress in ageing society/Increase 3 major ophthalmic diseases

Source the authority: United Nations Report

(unit: Million people)

Diabetic Retinopathy AMD Glaucoma

87 90

110

127 131 161

74 75 80

Source the authority: Market Scope and Topcon’s estimation

35

(Global)

©2014 Topcon Corporation

New Business OCT Sales

OCT Business Achievement and Target New business field

Current ophthalmology field

2013 2016 2012 2011

Imaging devices w/ Screening Treatment/Prognostic management

Launching OCT Maestro (Fully automatic operation for

everyone)

Launching OCT Atlantis (World-first deep-range

scanning) 180％ growth

160％ growth

36

©2014 Topcon Corporation

・ OCT makes various diseases visible →Create new added value by OCT+ Functional imaging

New Business OCT Sales 〈New business development〉

Major Strategy

◆Market size: 30 billion yen ◆Increasing ophthalmic diseases accompanying of ageing ・Diabetic Retinopathy ・AMD ・Glaucoma etc. ◆OCT market acceleratory expands from ophthalmology to Screening

Disruptive innovation generates additional value

New product (under development)

Make various diseases visible

2012年度 2013年度 2016年度

160%

OCT angiography

37

Market Potential

Sales Projection

FY2012 FY2013 FY2016

©2014 Topcon Corporation

2012年度 2013年度 2016年度

・Realize Smart Prognostic Management System by utilize CLOUD service Capture images at distant area →Diagnostic at hospital→Send report

New Business OCT Sales <Create Prognostic Business>

Major Strategy

◆Market size: 30 billion yen ◆Increasing patients accompanying of aging, improving diagnostic efficiency, and solving shortage of physicians ◆Expand follow-up needs by popularization of Anti-VEGF injections

Create Prognostic Management business by OCT with fully automatic operation

Follow up→ attend a hospital when treatment needed

Any Data Any Device Any Time Any Place

38

OCT with fully automatic operation device in prognostic management

World’s First

Sales Projection

Market Potential

FY2012 FY2013 FY2016

©2014 Topcon Corporation

・Expand physical check-up market by OCT (Improve reading efficacy) ・Offering Screening System by CLOUD service

New Business OCT Sales <Entering screening market>

Major Strategy

◆Market size: 82 billion yen ◆Increasing patients accompanying of ageing, Improve diagnostic efficiency/Solve shortage of physicians ◆Provide premium service even if at distant area

Expand Screening business by OCT with fully automatic operation

Local healthcare network

2012年度 2013年度 2016年度

200%

Any Data Any Device Any Time Any Place

Advanced analysis by CLOUD (Joint Lab with )

Screening by OCT with fully automatic operation

39

World’s First

Sales Projection

FY2012 FY2013 FY2016

Market Potential

©2014 Topcon Corporation

・Integration of Pattern laser & OCT for Treatment/ Prognostic Management ・Provide treatment device better tolerated by patient (less- pain/burden)

New Business Expand Treatment Device

Major Strategy

◆Market size: 70 billion yen ◆Increase in Diabetic retinopathy and Aged-related macular degeneration ◆Complex treatment by Laser + Anti-VEGF

Create synergy with Treatment & Retinal Imaging devices 180%

40

Treatment/ Prognostic Management

2012年度 2013年度 2016年度 Prognostic Management by

OCT with ease of use

Launching new product

Sales Projection

Market Potential

FY2012 FY2013 FY2016

©2014 Topcon Corporation

Strengthen Countermeasures to FDA

1 2

1

6

7

2010 2011 2012 2013 2014

Topcon FDA510(k) Trend for number of clearance models

・Enforce the capability for regulation of medical device in globally -Enforce organization for FDA regulation (Adopted 6 staffs who has a strong skill for FDA in U.S.) -Increase the number of Clearance: 1 model (FY2012)→ 7 models (expected in FY2014)

Enforce the capability for severe FDA condition

Enforce the organization Adopt FDA specialist

“T-GREAT”(Topcon-Global Regulatory Executive Affairs Team)

41

©2014 Topcon Corporation 42

FY2013 (Result)

FY2014 - FY2016 (Plan)

Strategic Product 3 models 10 models

Reduction of COGS 6 models 6 models

Products for emerging markets 0 model 4 Models

Total 9 Models 20 Models

New Products Launch

©2014 Topcon Corporation

Breakdown of Sales Growth

Examination/Diagnostic

Treatment/ Prognostic

Management

38.7

50.5

Preventive/ Check up

Eye Care Company

New Business （Preventive/Checkup, Treatment/Prognostic Management, Ophthalmic IT）

Core Business （Examination/Diagnostic）

43

FY 2013 Result Mid-term Plan 2016

(unit: billion yen)

Operating Income Ratio 10.3％

Operating Income Ratio 16.8％